000 | 01305 a2200361 4500 | ||
---|---|---|---|
005 | 20250515132051.0 | ||
264 | 0 | _c20081009 | |
008 | 200810s 0 0 eng d | ||
022 | _a0929-8673 | ||
024 | 7 |
_a10.2174/092986708785132870 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhou, Shu-Feng | |
245 | 0 | 0 |
_aSubstrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. _h[electronic resource] |
260 |
_bCurrent medicinal chemistry _c2008 |
||
300 |
_a1981-2039 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xmetabolism |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 | _aDrug Resistance, Multiple |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMultidrug Resistance-Associated Protein 2 |
650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xantagonists & inhibitors |
700 | 1 | _aWang, Lin-Lin | |
700 | 1 | _aDi, Yuan Ming | |
700 | 1 | _aXue, Charlie Changli | |
700 | 1 | _aDuan, Wei | |
700 | 1 | _aLi, Chun Guang | |
700 | 1 | _aLi, Yong | |
773 | 0 |
_tCurrent medicinal chemistry _gvol. 15 _gno. 20 _gp. 1981-2039 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/092986708785132870 _zAvailable from publisher's website |
999 |
_c18165330 _d18165330 |